Cardioprotective and survival benefits of long-term combined therapy with β2 adrenoreceptor (AR) agonist and β1 AR blocker in dilated cardiomyopathy postmyocardial infarction

Ismayil Ahmet, Melissa Krawczyk, Weizhong Zhu, Anthony Yiu Ho Woo, Christopher Morrell, Suresh Poosala, Riu Ping Xiao, Edward G. Lakatta, Mark I. Talan

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Cardioprotective and survival benefits of long-term combined therapy with β2 adrenoreceptor (AR) agonist and β1 AR blocker in dilated cardiomyopathy postmyocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences